It has been suggested that regulation of enzyme synthesis in microorganisms occurs by alterations in the levels of specific messenger RNA's.1 In these terms, induction results from an increased synthesis of messenger RNA (mRNA), and repression from inhibition of mRNA synthesis. Similar phenomena in mammals have recently been explained in the same way. Thus, increases in RNA synthesis have been regularly observed in systems where protein synthesis is stimulated by hor- was injected intraperitoneally to 118 rats. At least gest that i this case, at least, 6 rats were sacrificed each hour for the following other factors besides the level of 11 hr. The livers were rapidly removed, immediately frozen at-780C, and stored for 24 hr, at messenger RNA are involved in which time they were thawed and assayed for tryp-the regulation of enzyme syntophan pyrrolase (TP). The TP activity, expressed as gM kynurenine/gm liver/hr, represents the aver-thesis.
age of at least 6 separate animals. Results.-Course of tryptophan pyrrolase induction: As shown in numerous previous studies,4 the intraperitoneal injection of hydrocortisone to adrenalectomized animals resulted in a rapid increase in the level of TP in the liver. In the present experiments ( Fig. 1 ) (using hydrocortisone hemisuccinate), the maximum enzyme activity was reached in 5 hr, and this level was maintained for the next 2 hr, i.e., 5-7 hr after hormone administration.
Tryptophan pyrrolase degradation: Previous studies have shown that the hormone-induced increase in TP activity when assayed as in the present studies results from an increase in the rate of synthesis of the enzyme and is not due to activation of an inactive precursor.4' 11 As illustrated in Figure 1 , the induced level of TP falls to the basal level after several hours. Therefore, as previously suggested,'2' 13 enzyme degradation also plays a role in determining its intracellular concentration, and recently it has been suggested that regulation of enzyme levels may be mediated by changes in rates of degradation. and disappearance following induction was due to changes in its rate of degradation during the experimental period. For this purpose, puromycin was administered at different times after hormone administration (Fig. 2) . 16 Figure 2A depicts the decline in TP activity when puromycin was administered during the course of induction, and 2B shows a semilogarithmic plot of these data which illustrates that the decline in activity followed first-order kinetics with a four rats were injected with was assayed in each case 5 hr after hormone injection. Valhydrocortisone hemisuccinate as ues from actinomycin-treated animals (.) were compared described. Seven hr later 120 with hormone-treated animals which did not receive actinomg of L-tryptophan, dissolved mycin D (0). Each point represents the average tryptophan in 0.15 M NaCl, was adminis-pyrrolase activity of 6 rats. The range of enzyme activities tered intraperitoneally to 12 at each time point did not exceed 8 units. (B) The experirats, 6 of which were sacrificed mental conditions are the same as described under (A) except 2 hr later, i.e., 9 hr after hy-that actinomycin D was administered at 4, 5, and 9 hr after hordrocortisone. The remaining 6 mone treatment (-), and the values were compared with unrats were sacrificed 5 hr later, injected animals (0). Each point represents the average of at i.e., 12 hr after hydrocortisone. least 6 rats. The range of enzyme activities at each time point (B) L-Tryptophan (120 mg) was did not exceed 6 units. administered as in (A) to 6 adrenalectomized rats which were killed 5 hr later. Each point represents the average tryptophan pyrrolase activity of 6 rats as in Fig. 1 Fwith a range of enzyme activities at each time point of less than 8 enzyme units.
Messenger RNA (mRNA): In microorganisms, it is generally considered that the rate of enzyme synthesis is regulated by the concentration of mRNA. In the present case, abrupt variations in mRNA levels would have had to occur to account for the relatively sudden changes in the rate of TP synthesis observed after hormone induction.'8 Therefore, the role of RNA synthesis in TP induction was investigated by administering actinomycin D19 20 at different times after hydrocortisone injection, and observing the resulting levels of TP in the liver.
Basal messenger: The following studies indicate that the mRNA for TP synthesis in the absence of hormone, i.e., basal messenger, was not rapidly degraded. 21 The same doses of actinomycin, given 1 or 2 hr after the hormone, likewise inhibited TP synthesis (Fig. 4A) . These observations are consistent with a requirement for (DNA-dependent) RNA synthesis in the induction process.
Surprisingly, however, when the same dose of actinomycin was administered 4 hr after hydrocortisone (Fig. 4B) ilarly, when actinomycin was given at 5, 6, 7, 8, or 9 hr after hydrocortisone, the expected fall in enzyme level did not occur, and, indeed, frequently an increase in TP activity was seen. Figure 4B illustrates typical experiments in which actinomycin was given at 4, 5, or 9 hr after hormone administration.
The rise in TP activity produced by actinomycin was blocked by the simultaneous administration of puromycin (Fig. 5) , suggesting that actinomycin stimulated TP synthesis, rather than its activation.
In another experiment, TP activity fell from 24 to 14 units in the interval between 5 and 8 hr after hydrocortisone (5 mg) administration. When tryptophan (120 mg) was given at 5 hr, there was a slight rise from 24 to 37 units in this period, as expected. However, when tryptophan was given together with actinomycin (1.0 mg) at 5 hr, the enzyme rose to 50 units. This again indicates that actinomycin administration results in an increased TP synthesis when given later than 4 hr after hydrocortisone.
Another inhibitor of RNA synthesis, 5-fluorouracil (5-FU), also appeared to increase TP synthesis or prevent its fall when given 5 hr after hydrocortisone administration. Table 1 illustrates that in the interval between 7 and 9 hr after hormone treatment, the control levels of TP fell, while it apparently rose in rats which had also received 5-FU. Table 1 with the exception that tyrosine hourly to each of 12 rats. Points were taken and transaminase is assayed instead of tryptophan the liver was assayed 2 and 4 hr later, i.e., 7 and 9 hr pyrrolase. after hydrocortisone.
As a result of these findings, it seemed that the decrease in the rate of TP synthesis which occurs between 4 and 5 hr after hydrocortisone treatment required RNA synthesis. Furthermore, when TP synthesis had slowed (at 5 hr) or even had stopped completely (at 7 hr), it could be restarted by inhibitors of RNA synthesis, indicating that TP mRNA was present, but not functional, at these later times. It seemed that inhibition of RNA synthesis by actinomycin D (or 5-FU) later than 4 hr after hydrocortisone prevented the formation of a substance "TP repressor" which inhibited further TP synthesis.22 In addition, the "TP repressor" would have had to turn over considerably more rapidly than TP messenger, since when repressor synthesis was blocked by actinomycin or 5-FU, the repression disappeared, allowing TP synthesis to continue.
On the basis of these considerations, the appearance of "TP repressor" (i.e., about 4 hr after hydrocortisone) should inhibit the stimulation of TP synthesis by a second injection of hydrocortisone given after that time. As shown in Figure  6 , a second dose of hydrocortisone, 4 hr after the first, stilnulated TP synthesis as effectively as the original injection. However, when the second dose of hormone was given later than 4 hr (i.e., 5, 7, or 821 hr) after the initial injection (when TIP re- Figure 7 illustrates the effects of actinomycin D on TT synthesis induced by hydrocortisone. As with TP, actinomycin D blocked TT induction when given simultaneously with the steroid,' and induced TT synthesis was also inhibited when actinomycin D was administered 1 or 2 hr after hydrocortisone. Again, as with TP, actinomycin stimulated enzyme activity when given 4 hr or later after hormone treatment (Fig. 7) . 5-FU markedly stimulated TT synthesis when administered 5 hr after the hydrocortisone injection (Table 2) .
TT responded similarly to TP to additional doses of hydrocortisone, that is, a second dose given 4 hr after the first, was as effective as the original injection, but when administered 5, 7, or 8 hr later, the response was markedly inhibited. Therefore, similar mechanisms may operate in the regulation of both TT and TP synthesis, although we have not yet studied TT induction as extensively as that of TP.
Discussion.-The findings presented above suggest the following hypothesis to explain the kinetics of tryptophan pyrrolase induction by hydrocortisone.
(1) The hormone initially stimulates enzyme formation by an actinomycin-sensitive process presumably involving RNA synthesis. 5 (2) About 4 hr after hormone administration, when the rate of enzyme synthesis is maximal, a repressor appears which inhibits further enzyme synthesis by inhibiting the function of existing mRNA. (3) The appearance of the repressor is likewise actinomycin-sensitive and presumably represents a product (or products) from genes different from the structural genes of TP. (4) TP messenger RNA is relatively stable while the repressor has a rapid rate of turnover.
Obviously, the effects of hydrocortisone need not be due directly to the hormone but could result from secondary metabolic effects.
The possibility that the repressor acts to destroy mRNA seems unlikely since actinomycin D stimulated enzyme formation when enzyme synthesis had been either inhibited or completely arrested, indicating that mRNA was present, but not functioning, at these times.
The early action of hydrocortisone in stimulating enzyme synthesis does not seem to be due to reversing the effect of the repressor described above, since neither actinomycin D nor 5-FU, given without the hormone, stimulated enzyme production. Furthermore, the effectiveness of the first injection of hydrocortisone when compared with the relative ineffectiveness of a second injection, given after repressor appears, argues against the presence of repressor prior to steroid administration.
Recently it has been-found that actinomycin D accelerates the appearance of intestinal phosphatase in young mice.25 This increase in enzyme activity is steroiddependent, but unlike the present case, puromycin also stimulates phosphatase appearance, indicating that the process involves enzyme activation rather than de novo synthesis.
However, a phenomenon apparently very similar to the present findings has been reported by McAuslan, 26 in which the inhibition of pox-virus-induced thymidylate kinase synthesis was also reversed by actinomycin D. The results in this study were explained by postulating that actinomycin either inhibited the formation of a substance which destroyed mRNA, or operated by a mechanism similar to that suggested by the present study.
The present experiments imply that there is rapid turnover of the repressor, and it is interesting that Gallant and Stapleton27 have suggested that the repressor for alkaline phosphatase in E. coli also turns over rapidly. In mammals, since mRNA's are relatively stable compared with microorganisms,28-30 it might be expected that, as in the present case, inhibition of enzyme synthesis operates on messenger translation rather than inhibition of mRNA synthesis.
Summary.-(1) The mechanism of hydrocortisone-induced tryptophan pyrrolase and tyrosine transaminase synthesis in the liver of adrenalectomized rats has been studied. (2) Actinomycin D did not inhibit synthesis of the basal enzymes, but inhibited the induction of these enzymes when injected at early times after hormone administration. (3) Actinomycin D and 5-fluorouracil stimulated tryptophan pyrrolase and tyrosine transaminase synthesis when injected 5 hr or later after the hormone. (4) It is proposed that repression of the synthesis of these enzymes occurs at the level of messenger RNA translation.
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